| 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 L Ryom, A Cotter, R De Miguel, C Béguelin, D Podlekareva, JR Arribas, ... HIV medicine 21 (10), 617-624, 2020 | 155 | 2020 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 124 | 2022 |
| Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study DN Podlekareva, AMW Efsen, A Schultze, FA Post, AM Skrahina, ... The lancet HIV 3 (3), e120-e131, 2016 | 110 | 2016 |
| Factors Associated with the Development of Opportunistic Infections in HIV-1–Infected Adults with High CD4+ Cell Counts: A EuroSIDA Study D Podlekareva, A Mocroft, UB Dragsted, B Ledergerber, M Beniowski, ... The Journal of infectious diseases 194 (5), 633-641, 2006 | 104 | 2006 |
| Infection‐related and‐unrelated malignancies, HIV and the aging population L Shepherd, ÁH Borges, B Ledergerber, P Domingo, A Castagna, ... HIV medicine 17 (8), 590-600, 2016 | 88 | 2016 |
| Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina HIV/TB Study Writing Group Aids 23 (18), 2485-2495, 2009 | 72 | 2009 |
| Major revision version 11.0 of the European AIDS clinical society guidelines 2021 L Ryom, R De Miguel, AG Cotter, D Podlekareva, C Beguelin, ... HIV medicine 23 (8), 849-858, 2022 | 70 | 2022 |
| Short-and long-term mortality and causes of death in HIV/tuberculosis patients in Europe DN Podlekareva, AM Panteleev, D Grint, FA Post, JM Miro, M Bruyand, ... European Respiratory Journal 43 (1), 166-177, 2014 | 64 | 2014 |
| Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe FA Post, D Grint, AM Werlinrud, A Panteleev, V Riekstina, ... Journal of Infection 68 (3), 259-263, 2014 | 57 | 2014 |
| Improved survival among hospitalized patients with coronavirus disease 2019 (COVID-19) treated with remdesivir and dexamethasone. A nationwide population-based cohort study T Benfield, J Bodilsen, C Brieghel, ZB Harboe, M Helleberg, C Holm, ... Clinical Infectious Diseases 73 (11), 2031-2036, 2021 | 53 | 2021 |
| A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis: enhancing the safety of the TB patient World Health Organization World Health Organization, 2012 | 46 | 2012 |
| Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across E urope M Mansfeld, A Skrahina, L Shepherd, A Schultze, AM Panteleev, RF Miller, ... HIV medicine 16 (9), 544-552, 2015 | 44* | 2015 |
| Trajectory of cognitive impairments over 1 year after COVID‐19 hospitalisation: Pattern, severity, and functional implications KW Miskowiak, L Fugledalen, AE Jespersen, SM Sattler, D Podlekareva, ... European Neuropsychopharmacology 59, 82-92, 2022 | 42 | 2022 |
| Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial MN Polizzotto, J Nordwall, AG Babiker, A Phillips, DM Vock, N Eriobu, ... The Lancet 399 (10324), 530-540, 2022 | 42 | 2022 |
| Major challenges in clinical management of TB/HIV coinfected patients in Eastern Europe compared with Western Europe and Latin America AMW Efsen, A Schultze, FA Post, A Panteleev, H Furrer, RF Miller, ... PloS one 10 (12), e0145380, 2015 | 38 | 2015 |
| Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors A Kruk, W Bannister, DN Podlekareva, NP Chentsova, AG Rakhmanova, ... Aids 25 (12), 1505-1513, 2011 | 35 | 2011 |
| Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study T Benfield, J Bodilsen, C Brieghel, ZB Harboe, M Helleberg, C Holm, ... Clinical Infectious Diseases, ciab536, 2021 | 34 | 2021 |
| The EuroSIDA study: 25 years of scientific achievements K Laut, O Kirk, J Rockstroh, A Phillips, B Ledergerber, J Gatell, B Gazzard, ... HIV medicine 21 (2), 71-83, 2020 | 34 | 2020 |
| Antiretroviral drugs and risk of chronic alanine aminotransferase elevation in human immunodeficiency virus (HIV)-monoinfected persons: the data collection on adverse events of … H Kovari, CA Sabin, B Ledergerber, L Ryom, P Reiss, M Law, C Pradier, ... Open forum infectious diseases 3 (1), ofw009, 2016 | 33 | 2016 |
| Management of MDR-TB in HIV co-infected patients in Eastern Europe: results from the TB: HIV study AMW Efsen, A Schultze, RF Miller, A Panteleev, A Skrahin, ... Journal of Infection 76 (1), 44-54, 2018 | 32 | 2018 |
Marcelo H. LossoHead, HIV Unit, Hospital JM Ramos MejiaVerifisert e-postadresse på hivramos.org.ar
